Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

Acute Lymphoblastic Leukemia, Pediatric: early-phase trial registry

5 of 9 indexed Acute Lymphoblastic Leukemia, Pediatric trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Acute Lymphoblastic Leukemia, Pediatric: 9 US clinical trials tracked, 5 recruiting.

Acute Lymphoblastic Leukemia, Pediatric is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Cipherome, running 1 of these trials.

Enrollment posture brief

Registry condition acute-lymphoblastic-leukemia-pediatric

OPEN 5 | RECR 56% | LATE 1 | EARLY 2 | RANK #1916 | SPON 1

Volume-matched condition peers

Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)

Acute Spinal Cord Injury88.9%Acute Lymphoblastic Leuk (th…56%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Acute Lymphoblastic Leukemia, Pediatric

Acute Lymphoblastic Leukemia, Pediatric lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Lymphoblastic Leukemia, Pediatric on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Lymphoblastic Leukemia, Pediatric is recruiting above its size-band peers.

    5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Acute Lymphoblastic Leukemia, Pediatric trials is spread across many organizations.

    Cipherome accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Most Acute Lymphoblastic Leukemia, Pediatric trials plan to enrol fewer than 100 people.

    Median target enrolment is 70 among the 9 trials that report a genuine target (sentinel values excluded). 7 of those (77.8%) plan for fewer than 100 participants.

  4. Acute Lymphoblastic Leukemia, Pediatric research is mostly interventional.

    8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 31

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 3 1

Top Sponsors

Cipherome 1 trials
Tanja Andrea Gruber 1 trials
Children's National Research Institute 1 trials
Roswell Park Cancer Institute 1 trials
Dana-Farber Cancer Institute 1 trials
Columbia University 1 trials
Case Comprehensive Cancer Center 1 trials
Children's Hospital of Philadelphia 1 trials
Stanford University 1 trials

Named interventions

Most-linked intervention names on Acute Lymphoblastic Leukemia, Pediatric records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Cyclophosphamide Drug
2 trials
DASATINIB Drug
1 trials
CYTARABINE Drug
1 trials
Erwinia asparaginase Drug
1 trials
Low Glycemic Index Diet Behavioral
1 trials
Autologous CD22 CAR T Drug
1 trials
Use of Virtual Reality Headset Other
1 trials
Massage therapy Other
1 trials

US sites by state

Facility locations filed on Acute Lymphoblastic Leukemia, Pediatric trials. A trial with sites in several states counts in each.

New York 3 trials
District of Columbia 3 trials
California 3 trials
Pennsylvania 2 trials
Rhode Island 1 trials
Ohio 1 trials
New Jersey 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Acute Lymphoblastic Leukemia, Pediatric page

9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 5 Acute Lymphoblastic Leukemia, Pediatric trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Cipherome sponsors the most Acute Lymphoblastic Leukemia, Pediatric trials on record, review their full trial history before evaluating a specific study. See Cipherome's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Lymphoblastic Leukemia, Pediatric condition card totals 9 registered trials; most-linked intervention Cyclophosphamide; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.